Skip to main content
. 2022 Feb 14;12:715534. doi: 10.3389/fonc.2022.715534

Figure 6.

Figure 6

RAB41 is a target of miR-186 in OSCC cells. (A) The binding sites predicted by TargetScan7.2. (B) The binding sites verified by dual-luciferase reporter assay. (C) The interaction between RAB41 and miR-186 determined by RNA pull-down assay. (D) mRNA expression of RAB41 in OSCC cells detected using qRT-PCR. (E) Protein expression of RAB41 in OSCC cells measured using western blot. (F) Expression of RAB41 in OSCC clinical samples determined by qRT-PCR. (G) Correlation analysis of RAB41 and circFAM126A in clinical samples. (H) Correlation analysis of RAB41 and miR-186 in clinical samples. **P<0.01, ## P<0.01.